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Background 
Alnassar	  S	  et	  al.	  Incisional	  hernia	  post-­‐repair	  of	  abdominal	  aorIc	  occlusive	  and	  aneurysmal	  
disease:	  ﬁve-­‐year	  incidence.	  (2012)	  Vascular	  20:273-­‐277	  
Canadian	  study:	  204	  paIents	  
	  
*	  overall	  5	  year	  incidence	  of	  IH	  aVer	  
aorIc	  surgery:	  69.1%	  
	  
*	  median	  failure	  Ime	  was	  48	  
months	  
Background 
Henriksen NA et al. Risk factors for incisional hernia repair after aortic 
reconstructive surgery in a nationwide study. (2013) J Vasc Surg. 
Danish	  registers:	  2,597	  paIents	  
	  
*	  cumulaIve	  risk	  for	  hernia	  repair	  
aVer	  6	  years:	  10.4%	  
	  
*	  BMI	  >	  25	  kg/m2	  and	  AAA	  repair	  
were	  signiﬁcantly	  associated	  with	  
incisional	  hernia	  repair.	  	  
Objectives 
To	  reduce	  the	  incidence	  of	  incisional	  hernia	  24	  
months	  postoperaKvely	  aLer	  midline	  laparotomy	  
for	  treatment	  of	  AAA	  from	  25%	  to	  5%	  
Trial design 
A	  prospecKve,	  parallel	  groups,	  mulK-­‐center,	  	  
open	  label	  randomized	  trial	  
Inclusion criteria 
All	  paKents	  undergoing	  elecKve	  Abdominal	  Aorta	  
Aneurysm	  treatment	  through	  a	  midline	  
laparotomy	  are	  eligible	  for	  the	  trial.	  
Exclusion criteria 
•  Emergency	  surgery	  for	  aorKc	  aneurysm.	  
•  Presence	  of	  mesh	  in	  the	  abdominal	  wall	  on	  the	  
midline	  from	  previous	  operaKons	  
•  ASA	  score	  4	  or	  more	  
•  No	  informed	  consent	  
Material & Methods 
Control	  group	  	  
Closure	  of	  the	  abdomen	  with	  a	  
running	  single	  layer	  slowly	  
absorbable	  suture	  according	  to	  
the	  known	  recommendaKons	  
(SL/WL	  ≥	  4/1)	  for	  laparotomy	  
closure.	  	  
Material & Methods 
Treatment	  group	  	  	  
Closure	  of	  the	  abdomen	  
with	  implantaKon	  of	  a	  light	  
weight	  polypropylene	  mesh	  
(Ultrapro™)	  in	  a	  
retromuscular	  posiKon.	  
Width:	   	  7,5	  cm	  
Lenght:	   	  >	  incision	  +	  2x3cm	  




































































 NON-MESH MESH  
 (N= 58) (N= 56) 
   
Age at time of surgery (years) 71.9 (8.5) 72.3 (7.4) 
Women 12.1% (7/58) 3.6% (2/56) 
Body Mass Index (kg/m2) 26.5 (3.7) 25.5 (3.6) 
 ≥ 27 kg/m² 37.9% (22/58) 34.5% (19/55) 
 ≥ 30 kg/m² 8.6% (5/58) 10.9% (6/55) 
ASA score: Normal health  8.8% (5/57) 9.1% (5/55) 
 Mild to moderate systemic disease 61.4% (35/57) 61.8% (34/55) 
 Serious systemic disease 29.8% (17/57) 29.1% (16/55) 
 Life threatening systemic disease 0.0% (0/57) 0.0% (0/55) 
   
Risk factors   
 Chronic use of corticosteroids 5.3% (3/57) 1.9% (1/54) 
 Use of immuno-suppressive medication 0.0% (0/57) 0.0% (0/54) 
 Diabetes mellitus 17.9% (10/56) 17.0% (9/53) 
 Current smoker 63.0% (34/54) 66.0% (35/53) 
 Chronic obstructive pulmonary disease 35.2% (19/54) 27.3% (15/55) 
 Coronary heart disease 47.4% (27/57) 52.7% (29/55) 
 Hemodialysis 7.0% (4/57) 5.5% (3/55) 
 Previous malignancy 8.8% (5/57) 9.3% (5/54) 
 Previous midline incision 0.0% (0/52) 3.8% (2/52) 
 
Baseline data 
 NON-MESH MESH  
 (N= 58) (N= 56) 
   
Previous hernia operation   
 Inguinal hernia operation 17.5% (10/57) 17.9% (10/56) 
 Umbilical / Epigastric hernia operation 0.0% (0/57) 7.1% (4/56) 
 Incisional hernia operation 0.0% (0/57) 0.0% (0/56) 
   
Aortic aneurysm characteristics   
Maximum size (diameter) of the aneurysm 6.1 (1.5) 6.5 (1.4) 
Type of aneurysm: Infra-renal 77.2% (44/57) 91.1% (51/56) 
 Juxta-renal 21.1% (12/57) 7.1% (4/56) 
 Supra-renal 0.0% (0/57) 0.0% (0/56) 
 Involving iliac arteries 3.5% (2/57) 5.4% (3/56) 
Repair:  Straight tube 33.3% (19/57) 32.1% (18/56) 
 Bifurcation, intra-abdominal anastomosis 38.6% (22/57) 42.9% (24/56) 
 Bifurcation, distal anastomosis in the groin 28.1% (16/57) 25.0% (14/56) 
Previous aneurysm treatment:  None 94.7% (54/57) 92.7% (51/55) 
 Surgical 5.3% (3/57) 3.6% (2/55) 
 Endovascular 0.0% (0/57) 3.6% (2/55) 
   
Data are means (SD) or % (n/N);  
No significant difference between groups according to Fisher's exact test or Mann-Whitney U test !
Operative outcome 
 NON-MESH MESH  
 (N= 58) (N= 56) 
   
Length of fascia incision (cm)  28.3 (4.6) 26.9 (3.6) 
Length of suture used to close the fascia (cm)  111.8 (54.6) 93.9 (28.2) 
SL/WL ratio a 3.93 (1.61) 3.50 (0.98) 
SL/WL ratio ≥ 4 30.9% (17/55) 28.3% (13/46) 
Length of mesh used (cm) -- 32.3 (3.7) 
Estimated overlap of the mesh beyond the incision (cm) -- 3.26 (0.81) 
Number of fixation sutures used -- 12.4 (4.58) 
Drains used: None 55.2 % (32/58) 57.1% (32/56) 
 Retromuscular (on the mesh) 3.4% (2/58) 8.9% (5/56) 
 Retro- or intraperitoneal 37.9% (22/58) 32.1% (18/56) 
 Subcutaneous  1.7% (1/58) 3.6% (2/56) 
Duration of surgery:   
 Overall operation time (min) 189.7 (83.1) 211.5 (61.9) * 
 Time to close the abdominal wall (min) 29.6 (18.5) 46.2 (18.6) *** 
Intra-operative complications:   
 related to aneurysm surgery 5.2% (3/58) 5.4% (3/56) 
 related to abdominal wall closure 0.0% (0/58) 0.0% (0/56) 
Early postoperative complications b   
 None 51.7% (30/58) 55.4% (31/56) 
 Grade I 6.9% (4/58) 16.1% (9/56) 
 Grade II 19.0% (11/58) 12.5% (7/56) 
 Grade IIIa 1.7% (1/58) 0.0% (0/56) 
 Grade IIIb 1.7% (1/58) 8.9 (5/56) 
 Grade IV 12.1% (7/58) 5.4% (3/56) 
 Grade V (mortality) 6.9% (4/58) 1.8% (1/56) 
Hospital stay (days) 12.8 (10.6) 12.5 (7.4) 
   
Data are means (SD) or % (n/N); *P<0.05; **P<0.01; ***P<0.001 
a SL/WL ratio = Suture Length to Wound Length ratio 
b Classified)according)to)the)Clavien2Dindo)classification)of)postoperative)complications)6 
 
failure	  to	  get	  a	  SL/WL	  ≥	  4	  
in	  2/3	  of	  the	  paIents	  !	  
mesh	  augmentaIon	  took	  	  
17	  min	  extra	  !	  
Primary endpoint outcome 
 NON-MESH MESH  
 (N= 58) (N= 56) 
   
Observation time in event-free patients (years)   
 Mean (SD) 1.56 (0.71) 1.71 (0.56) 
 Median (P25-P75) 2.00 (1.36-2.00) 2.00 (1.73-2.00) * 
   
Number if IH's during 2 years following surgery 16 0 
Cumulative incidence, % 27.6 0.0 ** 
IH incidence rate (per 100 person-years) 20.7 0.0 
   
* P=0.66 (according to Mann-Whitney U test); ** P<0.0001 (according to Fisher's exact test) 
 
Primary endpoint outcome 
Log-­‐Rank	  test:	  P<0.0001	  
Conclusions 
•  Retromuscular	  mesh	  can	  prevent	  incisonal	  
hernia	  in	  AAA	  paKents	  with	  added	  operaKve	  
Kme	  of	  17	  min	  
•  No	  increased	  of	  morbidity	  
•  Interest	  in	  other	  paKents	  ?	  
•  How	  to	  implement	  in	  AAA	  surgery?	  	  
